4 NASH Clinical Trials in North Little Rock, AR (2026)

Q: How do I join a clinical trial in North Little Rock?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the North Little Rock research site will contact you.

Recruiting NASH Studies in North Little Rock

NCT07165028Recruiting

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

The main purpose of the SYNERGY-OUTCOMES study is to find out whether retatrutide and tirzepatide can prevent major adverse liver outcomes (MALO) in people with high-risk metabolic dysfunction-associa...

North Little Rock, AR4,500 participantsEli Lilly and Company

View Study Details

NCT06215716Recruiting

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

This is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study in subjects with non-cirrhotic NASH/MASH and fibrosis stage 2 or 3 (F2 or F3). The stud...

North Little Rock, AR1,650 participantsAkero Therapeutics, Inc

View Study Details

NCT06318169Recruiting

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

The study will assess the efficacy and safety of 2 dose regimens of pegozafermin for the treatment of liver fibrosis stage 2 or 3 in adult participants with MASH (previously known as nonalcoholic stea...

North Little Rock, AR1,350 participants89bio, Inc.

View Study Details

NCT06419374Recruiting

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

The study will assess the efficacy and safety of pegozafermin administered in participants with compensated cirrhosis due to MASH (biopsy-confirmed fibrosis stage F4 MASH \[previously known as nonalco...

North Little Rock, AR762 participants89bio, Inc.

View Study Details

About NASH Clinical Trials in North Little Rock

Nonalcoholic steatohepatitis (NASH/MASH) is a form of fatty liver disease involving liver inflammation and damage caused by fat buildup, not related to alcohol use. It can progress to fibrosis, cirrhosis, and liver failure. Treatment focuses on weight loss, lifestyle changes, and emerging pharmacological therapies.

There are currently 4 nash clinical trials recruiting participants in North Little Rock, AR. These studies are seeking a combined 8,262 participants. Research is being sponsored by Eli Lilly and Company, Akero Therapeutics, Inc, 89bio, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

NASH Clinical Trials in North Little Rock — FAQ

Are there nash clinical trials in North Little Rock?

Yes, there are 4 nash clinical trials currently recruiting in North Little Rock, AR. Browse the studies on this page to find one that fits.

How do I join a clinical trial in North Little Rock?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the North Little Rock research site will contact you about next steps.

Are clinical trials in North Little Rock free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many North Little Rock studies also compensate for your time and travel.

What nash treatments are being tested?

The 4 active trials in North Little Rock are testing new therapies including novel drugs, biologics, and treatment approaches for nash.

Data updated July 13, 2026 from ClinicalTrials.gov